BTI OF AMERICA, LLC

BTI Biotechnology Institute is a global medical device and regenerative medicine company specializing in oral implantology, plasma-rich growth factor (PRGF) regenerative medicine, and sleep apnea treatment solutions. The company operates a multidisciplinary team of over 300 professionals, with 20% dedicated to research and development. BTI manufactures and distributes dental implant systems, PRGF–ENDORET® product lines for tissue regeneration and wound healing applications, and sleep apnea therapeutic devices. The company maintains a strong international presence across more than 40 countries through direct affiliates and distributor networks. BTI emphasizes translational research from preclinical development through production, material treatment, and clinical application. The organization operates a dedicated training center offering comprehensive courses, webinars, and professional development programs for dental surgeons, orthopedic specialists, and sleep medicine practitioners. Research activities focus on advancing patient outcomes in oral implantology and regenerative medicine with clinical evidence-based methodologies.